This article was originally published on Opto – Invest in the Next Big Idea.
SPACs have seen a meteoric rise as pandemic-hit companies looked for alternative ways to raise capital. According to data from Dealogic, SPACs racked up $34.9bn in new issuances in February, making the $9.3bn from traditional IPOs seem almost paltry by comparison.
The frenzy has led to SPACs endorsed by celebrities like Shaquille O’Neal and launched by the business world’s big names, like Richard Branson and Bill Ackman. In his latest Opto column, veteran investor Frank Holmes notes that SPAC listings overtook IPOs last year:
“[In 2020] 248 SPACs listed, a record, compared to 209 traditional initial public offerings (IPOs). To my knowledge, this is the first time SPAC issuances outpaced IPO issuances.”
For Holmes, SPACs make it easier for a company to go public through an acquisition or reverse merger, as there are fewer regulatory hoops to jump through. They are also less costly than a traditional IPO. However, Holmes says he “wouldn’t be surprised if regulators start to crack down on these types of transactions”.
Recent reports in both Al Jazeera and the Financial Times back up Holmes’ concerns. In separate stories, the two news outlets report that the US Securities and Exchange Commission has requested information from those involved in the listing of these “blank cheque” companies. The Financial Times notes that, while banks and law firms have “enjoyed lucrative rewards and fees” from SPACs, critics have been increasingly vocal over investor protection and incentives. Al Jazeera reports that the regulator is concerned about underwriting the flood of deals coming from SPACs.
“This is the beginning of what I expect will be heightened scrutiny of trading and disclosures to investors arising from the surge of these transactions,” Doug Davison, a partner at Linklaters, told the Financial Times.
Are SPACs overvalued?
As valuations outpace the underlying fundamentals, there’s a danger that the SPAC boom is turning into a fad, with investors getting burnt in the process. The past month was particularly sobering, as the rise in treasury yields has caused a selloff in the market, with the IPOX SPAC Index experiencing an extended selloff at its February peak. Chamath Palihapitiya — a name now synonymous with blank cheque companies — even commented that “The SPAC market has taken a real beating,” on his podcast
“When the price is moving up way faster than fundamentals can justify, that screams risk to us, and people who have those exposures are experiencing that risk today,” Matt Stucky of Northwestern Mutual Wealth Management told Bloomberg.
Worryingly, the downturn in the performance of these investment vehicles has been more pronounced than the one seen in the wider market. A 9 March report from CNBC cites Bain & Co data showing that 60% of SPACs are lagging behind the S&P 500.
Taking a look at The Indxx SPAC & NextGen IPO Index, its top three holdings have all taken a bruising. Top holding DraftKings [DKNG] is down 15% over the past month and second-place Open Technologies [OPEN] has seen a steep 33% decline (as of 30 March’s close). In third place is Bill Ackman’s investment vehicle Pershing Square Tontine Holdings [PSTH] which has seen an 18% drop.
“There have been too many new issue listings and the market simply cannot handle the overflow,” Christopher Matthaei, a partner at Elevation Securities, which conducts SPAC research, told Al Jazeera.
Greater scrutiny means greater investor protection, and it’s unlikely that the SPAC will go away anytime soon — the City of London is already looking at how it can make it easier for SPACs to list so it doesn’t lose business to New York or Amsterdam.
SPACs are a way to raise cash for a listing, especially for innovative companies at a time when capital markets are under pressure. For example, Virgin Galactic listed via a SPAC.
One route for those interested in SPACs could be to consider a fund that gives exposure to the overall SPAC market. For example, The Defiance Next Gen SPAC Derived ETF [SPAK] is down 16.42% over the past month. The fund gives a 60% weighting to IPO companies derived from SPACs and 40% to newly listed, pre-merger SPACs. So, while some of its constituents have taken a beating over the past month, investors aren’t nursing the same heavy losses as if they’d invested in individual SPACs.
The other route to exposure is waiting for a SPAC to complete. After all, the end result is still a listed company that can be assessed at a fundamental level.
Either way, the old adage of doing homework before investing applies as ever.
MyWallSt operates a full disclosure policy. MyWallSt staff currently hold long positions in companies mentioned above. Read our full disclosure policy here.
Disclaimer Past performance is not a reliable indicator of future results.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.
CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.
*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.
Guest Author at MyWallSt
The investment universe is changing beyond all recognition, and with a thematic focus, investors can capitalise on this wholesale disruption. From Genomics to Artificial Intelligence, disruptive innovation empowers companies to displace industry incumbents, and secure majority market share. Opto exists to identify those businesses, and help investors to invest in the next big idea.